Heterogeneity in hormone responses and patterns of collagen synthesis in cloned dermal fibroblasts.
暂无分享,去创建一个
M. Stephenson | S. Krane | J. Korn | S. Goldring | E. Downie | Stephen M. Krane | Joseph H. Korn | M. L. Stephenson
[1] J. Hayman,et al. Parathyroid hormone‐related protein: Immunohistochemical localization in cancers and in normal skin , 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[2] S. Krane,et al. Interleukin 1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes. , 1988, The Journal of clinical investigation.
[3] P. Hebda,et al. Heterogeneous synthetic phenotype of cloned scleroderma fibroblasts may be due to aberrant regulation in the synthesis of connective tissues. , 1988, Arthritis and rheumatism.
[4] G. Strewler,et al. Synthetic peptides comprising the amino-terminal sequence of a parathyroid hormone-like protein from human malignancies. Binding to parathyroid hormone receptors and activation of adenylate cyclase in bone cells and kidney. , 1988, The Journal of biological chemistry.
[5] R. Nissenson,et al. Parathyroid hormone receptors in human dermal fibroblasts: Structural and functional characterization , 1988, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[6] S. Krane,et al. Modulation by recombinant interleukin 1 of synthesis of types I and III collagens and associated procollagen mRNA levels in cultured human cells. , 1987, The Journal of biological chemistry.
[7] G. Strewler,et al. Parathyroid hormonelike protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone. , 1987, The Journal of clinical investigation.
[8] E. Crouch,et al. Heterogeneity in the production of collagens and fibronectin by morphologically distinct clones of a human tumor cell line: evidence for intratumoral diversity in matrix protein biosynthesis. , 1987, Cancer research.
[9] E. Chen,et al. A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. , 1987, Science.
[10] A. F. Stewart,et al. N-terminal amino acid sequence of two novel tumor-derived adenylate cyclase-stimulating proteins: identification of parathyroid hormone-like and parathyroid hormone-unlike domains. , 1987, Biochemical and biophysical research communications.
[11] B. Berman,et al. Persistence of a reduced-collagen-producing phenotype in cultured scleroderma fibroblasts after short-term exposure to interferons. , 1987, The Journal of clinical investigation.
[12] P. Libby,et al. Mesenchymal target cell specificity of egg granuloma-derived fibroblast growth factor in schistosomiasis. , 1987, The Journal of infectious diseases.
[13] S. Goldring,et al. Human giant cell tumors of bone identification and characterization of cell types. , 1987, The Journal of clinical investigation.
[14] M. Stephenson,et al. Immune interferon suppresses levels of procollagen mRNA and type II collagen synthesis in cultured human articular and costal chondrocytes. , 1986, The Journal of biological chemistry.
[15] A. Moses,et al. Selective resistance to parathyroid hormone in cultured skin fibroblasts from patients with pseudohypoparathyroidism type Ib. , 1986, The Journal of clinical endocrinology and metabolism.
[16] R Dalgleish,et al. Human type III collagen gene expression is coordinately modulated with the type I collagen genes during fibroblast growth. , 1986, Biochemistry.
[17] R. Crystal,et al. Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators. , 1986, The Journal of clinical investigation.
[18] L. Liotta. Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture. , 1986, Cancer research.
[19] C. Brinckerhoff,et al. Synthesis of PGE2, collagenase and tissue factor by fibroblast substrains: substrains are differentially activated for different metabolic products. , 1985, Collagen and related research.
[20] S. Krane,et al. Influences of gamma interferon on synovial fibroblast-like cells. Ia induction and inhibition of collagen synthesis. , 1985, The Journal of clinical investigation.
[21] C. Silve,et al. A factor produced by cultured rat Leydig tumor (Rice 500) cells associated with humoral hypercalcemia stimulates adenosine 3',5'-monophosphate production via the parathyroid hormone receptor in human skin fibroblasts. , 1985, The Journal of clinical endocrinology and metabolism.
[22] J. Korn. Substrain heterogeneity in prostaglandin E2 synthesis of human dermal fibroblasts. Differences in prostaglandin E2 synthetic capacity of substrains are not stimulus-restricted. , 1985, Arthritis and rheumatism.
[23] M. Stephenson,et al. Immune interferon inhibits collagen synthesis by rheumatoid synovial cells associated wth decreaded levels of the procollagen mRNAs(FEBS 2156) , 1985 .
[24] S. Goldring,et al. Differential effects of parathyroid hormone responsive cultured human cells on biological activity of parathyroid hormone and parathyroid hormone inhibitory analogues. , 1985, Biochemistry.
[25] M. Stephenson,et al. Immune interferon inhibits collagen synthesis by rheumatoid synovial cells associated with decreased levels of the procollagen mRNAs. , 1985, FEBS letters.
[26] S. Krane,et al. Mononuclear cell-conditioned medium containing mononuclear cell factor (MCF), homologous with interleukin 1, stimulates collagen and fibronectin synthesis by adherent rheumatoid synovial cells: effects of prostaglandin E2 and indomethacin. , 1985, Collagen and related research.
[27] E. Vuorio,et al. Increased type I collagen mRNA levels in cultured scleroderma fibroblasts. , 1984, Biochimica et biophysica acta.
[28] J. Korn,et al. Clonal heterogeneity in the fibroblast response to mononuclear cell derived mediators. , 1984, Arthritis and rheumatism.
[29] S. Krane,et al. Photoaffinity labeling of parathyroid hormone receptors: comparison of receptors across species and target tissues and after desensitization to hormone. , 1984, Biochemistry.
[30] J. Korn. Fibroblast prostaglandin E2 synthesis. Persistence of an abnormal phenotype after short-term exposure to mononuclear cell products. , 1983, The Journal of clinical investigation.
[31] M L Chu,et al. Structure of a cDNA for the pro alpha 2 chain of human type I procollagen. Comparison with chick cDNA for pro alpha 2(I) identifies structurally conserved features of the protein and the gene. , 1983, Biochemistry.
[32] I. Weiß,et al. Increased procollagen mRNA levels in scleroderma skin fibroblasts. , 1983, The Journal of investigative dermatology.
[33] L. Liotta,et al. Tumor invasion and the extracellular matrix. , 1983, Laboratory investigation; a journal of technical methods and pathology.
[34] J. Myers,et al. Cloning and characterization of five overlapping cDNAs specific for the human pro alpha 1(I) collagen chain. , 1982, Nucleic acids research.
[35] B. White,et al. Cytoplasmic dot hybridization. Simple analysis of relative mRNA levels in multiple small cell or tissue samples. , 1982, The Journal of biological chemistry.
[36] E. Leroy,et al. Fibroblast selection in scleroderma , 1982 .
[37] E. Leroy,et al. Fibroblast selection in scleroderma. An alternative model of fibrosis. , 1982, Arthritis & Rheumatism.
[38] C. Brinckerhoff,et al. Collagenase production by cloned populations of rabbit synovial fibroblasts. , 1981, Collagen and related research.
[39] R. Crystal,et al. Regulation of Collagen Production by the β-Adrenergic System , 1981 .
[40] D. Rowe,et al. Parathyroid hormone alters collagen synthesis and procollagen mRNA levels in fetal rat calvaria. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[41] A. Eisen,et al. Scleroderma: increased biosynthesis of triple-helical type I and type III procollagens associated with unaltered expression of collagenase by skin fibroblasts in culture. , 1979, The Journal of clinical investigation.
[42] S. Krane,et al. Effects of human mononuclear cell factor on cultured rheumatoid synovial cells: Interactions of prostaglandin E2 and cyclic adenosine 3′,5′-monophosphate☆ , 1979 .
[43] S. Krane,et al. Parathyroid hormone inhibitors: comparison of biological activity in bone- and skin-derived tissue. , 1979, The Journal of clinical endocrinology and metabolism.
[44] Cotran Rs. Monocytes, proliferation, and glomerulonephritis. , 1978 .
[45] T. Pearson,et al. Clonal Markers in the Study of the Origin and Growth of Human Atherosclerotic Lesions , 1978, Circulation research.
[46] S. Krane,et al. Response to hormones of cells cultured from human giant cell tumors of bone. , 1978, The Journal of clinical endocrinology and metabolism.
[47] R. Cotran. Monocytes, proliferation, and glomerulonephritis. , 1978, The Journal of laboratory and clinical medicine.
[48] R. Page,et al. Fibroblast heterogeneity and prostaglandin regulation of subpopulations. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[49] R. Page,et al. Diphenylhydantoin (dilantin) gingival hyperplasia: drug-induced abnormality of connective tissue. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[50] J. R. Smith,et al. VARIATION IN THE LIFE-SPAN OF CLONES DERIVED FROM HUMAN DIPLOID CELL STRAINS , 1974, The Journal of cell biology.
[51] T. Norwood,et al. Clonal selection, attenuation and differentiation in an in vitro model of hyperplasia. , 1974, The American journal of pathology.
[52] E. Benditt,et al. Evidence for a monoclonal origin of human atherosclerotic plaques. , 1973, Proceedings of the National Academy of Sciences of the United States of America.